GB202207559D0 - Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders - Google Patents

Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders

Info

Publication number
GB202207559D0
GB202207559D0 GBGB2207559.2A GB202207559A GB202207559D0 GB 202207559 D0 GB202207559 D0 GB 202207559D0 GB 202207559 A GB202207559 A GB 202207559A GB 202207559 D0 GB202207559 D0 GB 202207559D0
Authority
GB
United Kingdom
Prior art keywords
diseases
treatment
conditions associated
movement disorders
flavonoid compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2207559.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ontrack Therapeutics Ltd
Original Assignee
Ontrack Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ontrack Therapeutics Ltd filed Critical Ontrack Therapeutics Ltd
Priority to GBGB2207559.2A priority Critical patent/GB202207559D0/en
Publication of GB202207559D0 publication Critical patent/GB202207559D0/en
Ceased legal-status Critical Current

Links

GBGB2207559.2A 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders Ceased GB202207559D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2207559.2A GB202207559D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2207559.2A GB202207559D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders

Publications (1)

Publication Number Publication Date
GB202207559D0 true GB202207559D0 (en) 2022-07-06

Family

ID=82220587

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2207559.2A Ceased GB202207559D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders

Country Status (1)

Country Link
GB (1) GB202207559D0 (en)

Similar Documents

Publication Publication Date Title
IL288214A (en) Quinazolin-4-one derivatives useful for the treatment of braf-associated diseases and disorders
IL287032A (en) Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
EP4031152A4 (en) Methods and probiotic compositions for the treatment of metabolic diseases and disorders
EP3583113A4 (en) Use of tgf alpha for the treatment of diseases and disorders
SG11202110174PA (en) Compositions and methods for the treatment of kras associated diseases or disorders
IL289167A (en) 2h-indazole derivatives and their use in the treatment of disease
IL287280A (en) Compounds and methods for the treatment of ocular disorders
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
EP3915985A4 (en) Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease
IL287264A (en) Compounds and methods for the treatment of ocular disorders
IL286268A (en) Pridopidine for use in the treatment of mitochondrial associated diseases and disorders, including symptoms thereof
IL272253A (en) Compositions and methods for treatment of inflammatory conditions and diseases of the skin
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders
PL3937948T3 (en) Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases
GB202304262D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
GB202207559D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
EP3955914A4 (en) Novel compounds and methods of use treating fructose-related disorders or diseases
IL309317A (en) Treatment of mtres1 related diseases and disorders
TWI799923B (en) Use of thioimidazolidinone drugs in the treatment of covid-19 disease
IL282562A (en) Composition and use for the treatment of parkinson's disease and related disorders
GB202211274D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
GB202207556D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
EP4017496A4 (en) Formulations for use in the prevention and/or treatment of peripheral neuropathy and its associated diseases
GB202217454D0 (en) Compounds for use in the treatment of diseases and conditions associated with anxiety and / or mood disorders
GB202217453D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)